The European Union's pharmaceutical sector is in a ongoing state of evolution. With rigorous regulations, increasing patient expectations, and the rapid pace of innovation, navigating this complex landscape requires a prudent approach. Pharmaceutical companies must evolve to such changes by integrating innovative technologies, collaborating with ke